Komori
Niterra (5334) · FactAchieved

Finalization of the purchase price allocation for the Spirosure, Inc. business acquisition

First written in FY2021-Q2. 1 of 1 entries say "Achieved", first in FY2021-Q2. Latest entry: FY2021-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Finalization of purchase price allocation for Spirosure business acquisitionA theme 1 companies write about · 0 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2021-Q2AchievedAnnual report

    「取得対価の配分について、第１四半期連結会計期間においては暫定的な会計処理を行っていましたが、当第２四半期連結累計期間に確定しています。」

    2020年6月2日に取得したSpirosure, Inc.の喘息診断機器等事業について、取得対価の配分が確定した。取得資産・引受負債の公正価値純額は678百万円、のれんは322百万円、移転対価は1,000百万円として確定開示されている。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Niterra's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Finalization of the purchase price allocation for the Spirosure, Inc. business acquisition | Niterra Co.,Ltd. (5334) | Komori